| Literature DB >> 31692262 |
Ritika Singh1, Selvambigai Manivannan1, Arjen M Krikken1, Rinse de Boer1, Nicola Bordin2,3, Damien P Devos2, Ida J van der Klei1.
Abstract
Here, we describe a novel peroxin, Pex37, in the yeast Hansenula polymorpha. H. polymorpha Pex37 is a peroxisomal membrane protein, which belongs to a protein family that includes, among others, the Neurospora crassa Woronin body protein Wsc, the human peroxisomal membrane protein PXMP2, the Saccharomyces cerevisiae mitochondrial inner membrane protein Sym1, and its mammalian homologue MPV17. We show that deletion of H. polymorpha PEX37 does not appear to have a significant effect on peroxisome biogenesis or proliferation in cells grown at peroxisome-inducing growth conditions (methanol). However, the absence of Pex37 results in a reduction in peroxisome numbers and a defect in peroxisome segregation in cells grown at peroxisome-repressing conditions (glucose). Conversely, overproduction of Pex37 in glucose-grown cells results in an increase in peroxisome numbers in conjunction with a decrease in their size. The increase in numbers in PEX37-overexpressing cells depends on the dynamin-related protein Dnm1. Together our data suggest that Pex37 is involved in peroxisome fission in glucose-grown cells. Introduction of human PXMP2 in H. polymorpha pex37 cells partially restored the peroxisomal phenotype, indicating that PXMP2 represents a functional homologue of Pex37. H.polymorpha pex37 cells did not show aberrant growth on any of the tested carbon and nitrogen sources that are metabolized by peroxisomal enzymes, suggesting that Pex37 may not fulfill an essential function in transport of these substrates or compounds required for their metabolism across the peroxisomal membrane.Entities:
Keywords: PXMP2; Pex37; Sym1; Wsc; peroxisome; yeast
Year: 2019 PMID: 31692262 PMCID: PMC7318627 DOI: 10.1111/febs.15123
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542
Proteins of the PXMP2 family in various species.
|
|
|
|
|
|---|---|---|---|
|
Sym1 YOR292c | Hp32g403 (MN379451) | WSC (EAA33867) | PXMP2 |
| Hp27g68 (MN379453) | EAA34618 | MPV17 | |
| Hp24g381 (MN379452) | EAA32569 | MPV17L1 | |
| Hp32g332 (MN379454) | EAA36527 | MPV17L2 | |
| EAA33195 |
Figure 1Proteins of the PXMP2 family. (A) Protein phylogeny and secondary structure features of PXMP2‐related proteins obtained with Foundation 45. Nc—Neurospora crassa; Sc—Saccharomyces cerevisiae; Hs—Homo sapiens; Hp— Hansenula polymorpha. Phylogenetic tree (left): Numbers represent the bootstraps values, while branch length represents the amino acidic substitution rates. Sequence feature representation (right): The black horizontal lines represent the protein's sequence. The predicted β‐strands and α‐helices are depicted by bars above each line in cyan and magenta, with the height of the bars representing the confidence of the prediction. Transmembrane helix predictions are depicted as green boxes underneath the secondary structure prediction. (B) Representation of a conserved portion in the sequence alignment of PXMP2 family proteins. Manually curated alignment obtained by ClustalOmega 39. Residues are colored according to their biochemical character.
Figure 2Hp32g403‐GFP localizes to peroxisomes. (A) FM images of H. polymorpha cells producing Hp32g403‐GFP together with DsRed‐SKL. Cells were grown to the mid‐exponential growth phase on glucose or grown for 8 h on methanol medium. In the merged image, the cell contours are indicated in white. The scale bar represents 2 μm. Representative images of two independent experiments are shown. (B) Western blot analysis of a carbonate extraction experiment using an organellar pellet (P3) of methanol‐grown WT cells producing Hp32g403‐GFP. Equal portions of the P3, pellet (P), and supernatant (S) were loaded per lane. Blots were decorated with anti‐GFP antibodies. The PMP Pex14 and matrix protein catalase were used as controls. A representative western blot of two independent experiments is shown. (C) Western blot of total cell extracts of glucose and methanol‐grown cells producing Hp32g403‐GFP. Pyruvate carboxylase (Pyc) was used as a loading control. A representative western blot of two independent experiments is shown.
Figure 3Localization of Hp32g332, Hp24g381, and Hp27g68. FM images of glucose‐/methylamine‐grown WT cells producing P‐driven (A) Hp32g332‐GFP stained with the vacuole marker FM4‐64, (B) Hp24g381‐GFP stained with the vacuole marker FM4‐64, or (C) Hp27g68‐GFP stained with MitoTracker. Cells were grown to the mid‐exponential growth phase on glucose/methylamine media. In the merged image, the cell contours are indicated in white. Scale bar represents 1 μm. Representative images of two independent experiments are shown.
Figure 4Growth analysis of Hp32g403‐deficient cells. Spot assays performed using WT and Hp32g403‐deficient cells. Cultures were serially diluted and spotted on agar plates containing the indicated carbon and nitrogen sources. A representative spot assay of two independent experiments is shown.
Figure 5Peroxisome abundance and distribution are altered in glucose‐grown Hp32g403‐deficient cells. (A) CLSM images of methanol‐grown WT and Hp32g403‐deficient cells producing the peroxisomal membrane marker Pmp47‐GFP. Representative images of two independent experiments are shown. (B) CLSM images of WT cells, Hp32g403‐deficient cells, and Hp32g403‐deficient cells expressing P‐driven human PXMP2. The peroxisomal matrix is marked by GFP‐SKL. Cells were grown to the mid‐exponential growth phase on glucose. The scale bar in A and B represents 1 μm. Representative images of two independent experiments are shown. (C) Organelle quantification (from Z‐stack images) in budding cells of the Hp32g403‐deficient strain with and without P‐driven human PXMP2, together with the WT control strain, for the presence or absence of peroxisomes in the mother and daughter cells. All strains produced GFP‐SKL as peroxisomal marker. Peroxisomes from 2 × 70 budding cells were counted from two independent experiments. Error bar represents standard deviation. The statistics represent a Student t‐test, *P < 0.05. ns—P > 0.05. (D) EM analysis of glucose‐grown WT cells and Hp32g403‐deficient cells (CW, cell wall; ER, endoplasmic reticulum; M, mitochondria; P, peroxisome; V, vacuole). Representative cell sections from one experiment are shown.
Figure 6Hp32g403 overproduction results in enhanced numbers of peroxisomes in glucose‐grown cells. FM images of glucose‐grown WT (A) and Hp32g403‐overproducing cells (P‐Hp32g403) (B). FM images of two independent experiments are shown. EM analysis of WT (C) and the Hp32g403‐overproducing strain (D) (P—peroxisome; CW—cell wall; ER—endoplasmic reticulum). Representative cell sections from one experiment are shown. FM images of glucose‐grown dnm1 (E) and dnm1 cells overproducing Hp32g403 (F). Representative images of two independent experiments are shown. In A, B, E, and F, peroxisomes are marked by the matrix protein GFP‐SKL. Scale bars represent 1 μm in A, B, E, and F and 200 nm in C and D.
Figure 7Hp32g403 overproduction results in smaller peroxisomes. Quantification of the peroxisome diameter of glucose‐grown WT and Hp32g403‐overproducing cells using EM. For each strain, one culture was grown and analyzed by EM. For each strain, 22 peroxisomes are measured and depicted in an interquartile box together with the diameter of the individual peroxisomes.
Figure 8Human PXMP2 partially localizes to peroxisomes in Hansenula polymorpha. FM images of Hp32g403‐deficient cells producing PXMP2‐GFP under control of the promoter together with P ‐driven DsRed‐SKL as a peroxisome matrix marker. Cells were grown on glucose medium. Scale bar represents 1 μm. A representative image of two independent cultures is shown.
Yeast strains used this study.
| Strains | Characteristics | Reference |
|---|---|---|
| WT | NCYC495 |
|
| WT. DsRed‐SKL | WT cells with integration of plasmid pHIPX7‐DsRed‐SKL | This study |
| WT. DsRed‐SKL.Pex37‐mGFP | WT.DsRed‐SKL with integration of plasmid pSEM060 | This study |
| WT. DsRed‐SKL pHIPZ‐Hp32g332‐mGFP | WT.DsRed‐SKL integrated with plasmid pHIPZ‐Hp32g332‐mGFP | This study |
| WT. DsRed‐SKL pHIPZ‐Hp27g68‐mGFP | WT.DsRed‐SKL integrated with plasmid pHIPZ‐Hp27g68‐mGFP | This study |
| WT. DsRed‐SKL pHIPZ‐Hp24g381‐mGFP | WT.DsRed‐SKL integrated with plasmid pHIPZ‐Hp27g68‐mGFP | This study |
| WT.Pex14mKATE2 pHIPZ5‐Hp27g68‐mGFP | WT.Pex14mKATE2 with integrated pHIPZ5‐Hp27g68‐mGFP | This study |
| WT.Pex14mKATE2pHIPZ5‐Hp24g381‐mGFP | WT.Pex14mKATE2 integrated with pHIPZ5‐Hp24g381‐mGFP | This study |
| WT.Pex14mKATE2pHIPZ5‐Hp32g332‐mGFP | WT.Pex14mKATE2 integrated with pHIPZ5‐Hp32g332‐mGFP | This study |
| WT.Pmp47‐GFP | WT cells integrated with plasmid containing P |
|
|
|
| This study |
| WT.GFP‐SKL | WT cells integrated with plasmid containing pHIPX7‐GFP‐SKL |
|
|
|
| This study |
|
|
| This study |
| WT.Pex14mKATE2 | WT cells integrated with plasmid containing pHIPH‐Pex14‐mKATE2 | This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
|
|
|
|
| This study |
|
|
| This study |
Plasmids used in this study.
| Plasmid | Description | Reference |
|---|---|---|
| pHIPX7‐DsRed‐SKL | Plasmid containing P |
|
| pHIPZ‐mGFP fusinator | pHIPZ plasmid containing mGFP and |
|
| pSEM060 | Plasmid containing C‐terminal part of | This study |
| pHIPZ‐Hp32g332‐mGFP | Plasmid containing Hp32g332 fused with GFP, ampR, zeoR | This study |
| pHIPZ‐Hp27g68‐mGFP | Plasmid containing Hp27g68 fused with GFP, ampR, zeoR | This study |
| pHIPZ‐Hp24g381‐mGFP | Plasmid containing Hp27g68 fused with GFP, ampR, zeoR | This study |
| pDONR‐P4‐P1R | Standard Gateway vector | Invitrogen |
| pDONR‐P2R‐P3 | Standard Gateway vector | Invitrogen |
| pENTR‐221‐HPH | pENTR‐221 containing hygromycin marker, hphR, kanR |
|
| pDEST‐R4‐R3 | Standard destination vector | Invitrogen |
| pENTR‐41‐ | pDONOR‐P4‐P1 containing 5′ region of Hp32g403, kanR | This study |
| pENTR‐23‐ | pDONOR‐P2R‐P3 containing 3′ region of Hp32g403, kanR | This study |
| pSEM027 | pDEST‐R4‐R3 containing | This study |
| pHIPZ5 Nia | Plasmid containing multiple cloning site and |
|
| pHIPX7 GFP‐SKL | Plasmid containing GFP‐SKL under the control of |
|
| pHIPZ7‐GFP‐SKL | Plasmid containing GFP‐SKL under the control of |
|
| pHIPZ5‐Hp27g68‐mGFP | Plasmid containing Hp27g68 fused to GFP under control of P | This study |
| pHIPZ5‐Hp24g381‐mGFP | Plasmid containing Hp24g381 fused to GFP under control of P | This study |
| pHIPZ5‐Hp32g332‐mGFP | Plasmid containing Hp32g332 fused to GFP under control of P | This study |
| pHIPZ‐PMP47‐mGFP | Plasmid containing PMP47‐mGFP under the control of P |
|
| pHIPZ18‐eGFP‐SKL | pHIPZ containing eGFP.SKL under control of P | This study |
| pHIPZ4‐GFP‐SKL | pHIPZ4 containing eGFP.SKL, zeoR, ampR |
|
| pHIPN18‐eGFP‐SKL | pHIPN containing eGFP.SKL under control of P | This study |
| pHIPN4 | Plasmid containing ampR, natR |
|
| pHIPN18‐ | pHIPN containing | This study |
| pHIPN18‐DsRed‐SKL | pHIPN containing DsRed.SKL under control of P | This study |
| pHIPZ4‐DsRed‐SKL | Plasmid containing DsRed.SKL, zeoR |
|
| pHIPZ7‐PXMP2‐2HA | pHIPZ containing human | This study |
| pUC57‐PXMP2 plasmid | pUC57 containing human | This study |
| pHIPZ7 | pHIPZ plasmid containing |
|
| pHIPZ7‐PXMP2‐mGFP | pHIPZ containing human | This study |
Primers used in this study.
| P1 |
|
| P2 |
|
| Hp32g332 Fwd |
|
| Hp32g332 Rev |
|
| P3 |
|
| P4 |
|
| P5 |
|
| P6 |
|
| Fwd attB4 |
|
| Rev attb1 |
|
| Fwd attB2 |
|
| Rev attB3 |
|
| PEX37 del. Fwd |
|
| PEX37 del. Rev |
|
| P7 (Hp27gBamHI‐F) |
|
| P8 (Hp27gNdeI‐R) |
|
| P9 (Hp24gBamHI‐F) |
|
| P10 (Hp24gNdeI‐R) |
|
| P11 (Hp32gBamHI‐F) |
|
| P12 (Hp32gSpeI‐R) |
|
| Adh1‐F |
|
| Adh1‐R |
|
| PEX37 fw |
|
| PEX37 rev |
|
| PTEFNruI_F |
|
| TEFPxmp2BglII_R |
|